Characteristics Value, n (%)
Age (years), mean±standard deviation 61.1±9.7
BMI (kg/m2), mean±standard deviation 29.1±7.9
Co-morbidities
Yes 122 (47.6)
No 134 (52.4)
Tumor size (cm)
>3 78 (30.4)
≤3 168 (69.6)
Myometrial invasion
<50% 82 (32)
≥50% 174 (68)
FIGO Grade
Grade I 137 (53.5)
Grade II 63 (24.6)
Grade III 56 (21.9)
LVSI
Yes 64 (25)
No 194 (75)
Lymphadenectomy
Pelvic 25 (9.7)
Pelvic and para-aortic 165 (64.5)
None 66 (25.8)
Lymph Node Involvement
No 175 (89.7)
Yes 20 (10.3)
Adjuvant Treatment
None 103 (40.2)
Radiotherapy 129 (50.5)
Chemoradiotherapy 16 (6.2)
Chemotherapy 8 (3.1)
Recurrences (n)
No 239 (93.3)
Total recurrences 17 (6.7)
Vaginal/ local 4 (1.6)
Pelvic 3 (1.2)
Distant 10 (3.9)